Navigation path

HOME
Policy areas
Sectors
Who is in charge?
Competition and you
Cases
In this section:
Overview
What's new?
Official Journal
Legislation >
Cases
Statistics
Publications (Antitrust and Cartels)
Leniency
Whistleblower
Settlement
Compliance (Antitrust)
Practical information (Antitrust and Cartels)

Cartels

Cartel Cases

36957 Glaxo Wellcome

Companies: GSK / Glaxo Wellcome (E) / Glaxo-Wellcome
Economic Activity: C.21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
Events:
Date Document Type Document
27.05.2014 Rejection Decision en pdf  Published on 23.09.2014
08.05.2001 Prohibition Decision (Art. 101 & 102 Ex 81 & 82) Official Journal L 302, 2001, P. 0001 - 0043:
Multilingual
08.05.2001 Press Release Commission prohibits Glaxo Wellcome's dual pricing system in Spain:
en
These publications are for information purposes only and should not be considered as an official publication

New Search

Help on how to use the case search tool